Head-to-head comparison of two SGLT-2 inhibitors on AKI outcomes in a rat ischemia-reperfusion model-Reference-Cited by-同舟云学术

Head-to-head comparison of two SGLT-2 inhibitors on AKI outcomes in a rat ischemia-reperfusion model

Published:2022-09 Issue: Volume:153 Page:113357
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Chu Chang,Delić Denis,Alber Jana,Feger Martina,Xiong Yingquan,Luo Ting,Hasan Ahmed A.,Zeng Shufei,Gaballa Mohamed M.S.,Chen Xin,Yin Lianghong,Klein Thomas,Elitok Saban,Krämer Bernhard K.,Föller Michael,Hocher Berthold

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference51 articles.

1. Treatment of acute renal failure;Star;Kidney Int.,1998

2. Ischemia and reperfusion--from mechanism to translation;Eltzschig;Nat. Med.,2011

3. The SGLT2 inhibitor empagliflozin might be a new approach for the prevention of acute kidney injury;Chu;Kidney Blood Press Res.,2019

4. Antifibrotic effects of low dose SGLT2 Inhibition with empagliflozin in comparison to Ang II receptor blockade with telmisartan in 5/6 nephrectomised rats on high salt diet;Zeng;Biomed. Pharm.,2022

5. Investigators, canagliflozin and renal outcomes in Type 2 diabetes and nephropathy;Perkovic;N. Engl. J. Med.,2019

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse cardiovascular and kidney outcomes in people with SARS-CoV-2 treated with SGLT2 inhibitors;Communications Medicine;2024-09-11

2. EValuating the Effect of periopeRaTIve empaGliflOzin on cardiac surgery associated acute kidney injury: rationale and design of the VERTIGO study;Clinical Kidney Journal;2024-07-22

3. Unlocking renal Restoration: Mesaconine from Aconitum plants restore mitochondrial function to halt cell apoptosis in acute kidney injury;International Immunopharmacology;2024-05

4. SGLT2 Inhibitors and Kidney Protection: Mechanisms Beyond Tubuloglomerular Feedback;Kidney360;2024-03-25

5. Sodium-Glucose Co-Transporter 2 Inhibitors: Mechanism of Action and Efficacy in Non-Diabetic Kidney Disease from Bench to Bed-Side;Journal of Clinical Medicine;2024-02-07